1. Home
  2. ASC vs EOLS Comparison

ASC vs EOLS Comparison

Compare ASC & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardmore Shipping Corporation

ASC

Ardmore Shipping Corporation

HOLD

Current Price

$11.27

Market Cap

497.7M

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$7.19

Market Cap

444.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASC
EOLS
Founded
2010
2012
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
497.7M
444.0M
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
ASC
EOLS
Price
$11.27
$7.19
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$13.67
$20.80
AVG Volume (30 Days)
592.0K
1.1M
Earning Date
11-05-2025
11-05-2025
Dividend Yield
8.53%
N/A
EPS Growth
N/A
N/A
EPS
0.78
N/A
Revenue
$309,326,000.00
$285,823,000.00
Revenue This Year
N/A
$14.36
Revenue Next Year
N/A
$23.27
P/E Ratio
$14.30
N/A
Revenue Growth
N/A
15.10
52 Week Low
$8.32
$5.71
52 Week High
$13.85
$17.12

Technical Indicators

Market Signals
Indicator
ASC
EOLS
Relative Strength Index (RSI) 33.90 56.66
Support Level $11.07 $6.83
Resistance Level $12.41 $7.29
Average True Range (ATR) 0.29 0.26
MACD -0.14 0.02
Stochastic Oscillator 11.01 88.17

Price Performance

Historical Comparison
ASC
EOLS

About ASC Ardmore Shipping Corporation

Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The Company operates its business in one operating segment, the transportation of refined petroleum products and chemicals.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: